Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

ImmuneBiotech Medical Sweden AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 2,824 Less Arrow 2,412 Less Arrow 1,643
Financial expenses 0 Equal arrow 0 More Arrow 12
Earnings before taxes -7,456 More Arrow -5,780 More Arrow -5,629
EBITDA -7,683 More Arrow -5,667 More Arrow -5,458
Total assets 14,865 More Arrow 22,259 Less Arrow 7,534
Current assets 14,812 More Arrow 22,074 Less Arrow 7,219
Current liabilities 834 Less Arrow 772 Less Arrow 476
Equity capital 14,031 More Arrow 21,487 Less Arrow 7,058
- share capital 74 Equal arrow 74 Less Arrow 67
Employees (average) 3 Less Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 94.4% More Arrow 96.5% Less Arrow 93.7%
Turnover per employee 941 More Arrow 1,206 More Arrow 1,643
Profit as a percentage of turnover -264.0% More Arrow -239.6% Less Arrow -342.6%
Return on assets (ROA) -50.2% More Arrow -26.0% Less Arrow -74.6%
Current ratio 1776.0% More Arrow 2859.3% Less Arrow 1516.6%
Return on equity (ROE) -53.1% More Arrow -26.9% Less Arrow -79.8%
Change turnover 412 More Arrow 769 More Arrow 952
Change turnover % 17% More Arrow 47% More Arrow 138%
Chg. No. of employees 1 Equal arrow 1 Less Arrow 0
Chg. No. of employees % 50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.